Sunesis to Present at the Jefferies 3rd Annual Healthcare Conference
16 June 2009 - 10:00PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a biopharmaceutical
company focused on the development and commercialization of new
oncology therapeutics for the treatment of solid and hematologic
cancers, today announced that Daniel Swisher, Chief Executive
Officer of Sunesis, will be presenting at the Jefferies 3rd Annual
Healthcare Conference at 10:45 a.m. Eastern Time in New York on
June 17, 2009. The live webcast of this presentation will be
available on the Sunesis website at http://ir.sunesis.com/. A
replay of the webcast will be archived on the "Calendar of Events"
page in the Investors and Media section of the Sunesis website for
two weeks. About Sunesis Pharmaceuticals Sunesis is a
biopharmaceutical company focused on the development and
commercialization of new oncology therapeutics for the treatment of
solid and hematologic cancers. Sunesis has built a highly
experienced cancer drug development organization committed to
advancing voreloxin in multiple indications to improve the lives of
people with cancer. For additional information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/. SUNESIS and
the logo are trademarks of Sunesis Pharmaceuticals, Inc. Investor
Contact: Media Contact: Sunesis Pharmaceuticals, Inc. Sunesis
Pharmaceuticals, Inc. Eric Bjerkholt Dan Weinseimer 650-266-3717
650-266-3739 DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT:
Investors, Eric Bjerkholt, +1-650-266-3717, or Media, Dan
Weinseimer, +1-650-266-3739, both of Sunesis Pharmaceuticals, Inc.
Web Site: http://www.sunesis.com/
Copyright